Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer

SIMPLE SUMMARY: Immunotherapy offers new hope for patients with recurrent or metastatic head and neck cancer. However, only 20% of patients respond to this treatment. Combining radiotherapy in novel ways with immunotherapy can lead to synergistic effect by enabling cancer recognition by immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Plavc, Gaber, Jesenko, Tanja, Oražem, Miha, Strojan, Primož
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692120/
https://www.ncbi.nlm.nih.gov/pubmed/33143094
http://dx.doi.org/10.3390/cancers12113197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692120/
https://www.ncbi.nlm.nih.gov/pubmed/33143094
http://dx.doi.org/10.3390/cancers12113197

Ejemplares similares